Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The American Journal of Hospice & Palliative Care|January 19, 2011
Utility of the APACHE IV, PPI, and combined APACHE IV with PPI for predicting overall and disease-specific ICU and ACU mortalityJennifer A Burkmar, Rajesh IyengarThe Journal of Organic Chemistry|December 17, 2005
Revisiting a classic approach to the Aspidosperma alkaloids: an intramolecular Schmidt reaction mediated synthesis of (+)-aspidospermidineRajesh Iyengar, Klaas Schildknegt, Martha Morton, et al.The American Journal of Hospice & Palliative Care|December 5, 2009
APACHE IV versus PPI for predicting community hospital ICU mortalityShaffer R Shrope-Mok, Katie A Propst, Rajesh IyengarCurrent Topics in Medicinal Chemistry|September 28, 2007
Lead optimization strategies and tactics applied to the discovery of melanin concentrating hormone receptor 1 antagonistsPhilip R Kym, Andrew S Judd, John K Lynch, et al.Cell Metabolism|June 7, 2006
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndromeBarbara Cool, Bradley Zinker, William Chiou, et al.European Journal of Pharmacology|June 13, 2006
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxietyAna M Basso, Natalie A Bratcher, Kelly B Gallagher, et al.Journal of Medicinal Chemistry|March 31, 2006
Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonistsPhilip R Kym, Andrew J Souers, Thomas J Campbell, et al.Journal of Medicinal Chemistry|October 27, 2006
Optimization of chromone-2-carboxamide melanin concentrating hormone receptor 1 antagonists: assessment of potency, efficacy, and cardiovascular safetyJohn K Lynch, Jennifer C Freeman, Andrew S Judd, et al.Journal of Medicinal Chemistry|September 16, 2005
Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonistsPhilip R Kym, Rajesh Iyengar, Andrew J Souers, et al.Pageof 1